Locally Advanced Pancreatic Cancer Global Market Report 2025

Global Locally Advanced Pancreatic Cancer Market Report 2025

Locally Advanced Pancreatic Cancer Global Market Report 2025 - By Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery ), By Route Of Administration (Oral, Injectables, Other Route Of Administrations), By End-User (Hospital, Specialty Clinics, Research Institutions, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Name: Locally Advanced Pancreatic Cancer Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Locally Advanced Pancreatic Cancer Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Locally Advanced Pancreatic Cancer Global Market Report 2025

Proud Members Of

What Is Covered Under Locally Advanced Pancreatic Cancer Market

Locally advanced pancreatic cancer (LAPC) refers to a stage of pancreatic cancer where the tumor is confined to the pancreas and surrounding tissues but has not spread to distant organs. This cancer is usually not suitable for surgical removal due to its involvement with vital blood vessels or nearby structures.

The therapies available in the locally advanced pancreatic cancer include chemotherapy, immunotherapy, radiation therapy, and surgery. Chemotherapy involves the use of drugs to destroy cancer cells or inhibit their growth. These therapies can be administered through various routes, such as oral, injectable, and others, and are utilized in hospitals, specialty clinics, research institutes, and other healthcare settings.

How Is The Locally Advanced Pancreatic Cancer Market Segmented?

The locally advanced pancreatic cancer market covered in this report is segmented –

1) By Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, Surgery

2) By Route Of Administration: Oral, Injectables, Other Route Of Administrations

3) By End-User: Hospital, Specialty Clinics, Research Institutions, Other End-Users

Subsegments:

1) By Chemotherapy: Gemcitabine-based Chemotherapy, FOLFIRINOX Chemotherapy

2) By Immunotherapy: Immune Checkpoint Inhibitors, cancer vaccines

3) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT)

4) By Surgery: Pancreaticoduodenectomy (Whipple Procedure), Distal Pancreatectomy, Total Pancreatectomy

Locally Advanced Pancreatic Cancer Market Size and growth rate 2025 to 2029: Graph

What Is The Locally Advanced Pancreatic Cancer Market Size 2025 And Growth Rate?

The locally advanced pancreatic cancer market size has grown rapidly in recent years. It will grow from $0.95 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increase in awareness of pancreatic cancer, improved chemotherapy regimens, growth in use of targeted therapies, rise in incidence of pancreatic cancer, development of combination treatment protocols, and enhanced supportive care options.

What Is The Locally Advanced Pancreatic Cancer Market Growth Forecast?

The locally advanced pancreatic cancer market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increase in awareness of pancreatic cancer, improved chemotherapy regimens, growth in use of targeted therapies, rise in incidence of pancreatic cancer, development of combination treatment protocols, and enhanced supportive care options. Major trends in the forecast period include advancements in immunotherapy, development of targeted therapies, enhanced precision radiation techniques, improved diagnostic imaging, adoption of minimally invasive surgical approaches, integration of artificial intelligence in treatment planning, and advancements in combination therapy.

Book your 30 minutes free consultation with our research experts

What Is Driving The Locally Advanced Pancreatic Cancer Market: Impact Of Rising Tobacco Consumption On Health Risks

The increase in tobacco consumption is expected to drive the growth of the locally advanced pancreatic cancer markets going forward. Tobacco is a plant whose leaves are used in products such as cigarettes and cigars. It contains nicotine, which is addictive and is linked to serious health issues such as cancer and heart disease. The rising tobacco consumption is driven by factors such as easy access, affordability, tobacco marketing, social acceptance in some areas, and stress-related smoking. Tobacco consumption is a significant risk factor for the development of locally advanced pancreatic cancer, as it contributes to the increased incidence of pancreatic malignancies. For instance, in January 2024, according to the Global Action to End Smoking, a US-based non-profit organization for research related to end the smoking epidemic, in 2022, around 62.9 million adults in the U.S. used tobacco, ranking it 4th globally and 1st in the Americas. Further, around 11.5% of U.S. adults (28.3 million) smoked cigarettes, with higher rates among males (13.1%) than females (10.1%). Therefore, the increase in tobacco consumption is driving the growth of the locally advanced pancreatic cancer market.

Who Are The Major Players In The Global Locally Advanced Pancreatic Cancer Market?

Major companies operating in the locally advanced pancreatic cancer market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Ipsen Biopharmaceuticals Inc., Lupin Limited, NovoCure Limited, Theratechnologies Inc., XBiotech, Prestige Biopharma, OSE Immunotherapeutics, Helix Biopharma Corporation, Fawn Incorporation, Eli Lilly and Co

What Are The Key Trends Of The Global Locally Advanced Pancreatic Cancer Market: Innovative Approaches In Treating Rare Cancers With Orphan Drugs

Major companies operating in the locally advanced pancreatic cancer market are focusing on developing innovative products, such as orphan drugs, to enhance treatment options, improve patient outcomes, and address the unmet medical needs associated with this aggressive disease. Orphan drugs are designed to treat rare diseases affecting a small group of people and are incentivized by authorities with benefits such as tax reductions and market exclusivity to promote their development. For instance, in January 2025, Actuate Therapeutics Inc., a US-based biopharmaceutical company, announced that its Elraglusib, a new GSK-3ß inhibitor, has received Orphan Drug Designation from both the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) for treating pancreatic ductal adenocarcinoma (PDAC) (a potential types of locally advanced pancreatic cancer). This recognition highlights its potential to fill a critical gap in treating this severe cancer, especially after promising Phase 2 trial results showing significant clinical improvements and anti-tumor effects in metastatic PDAC patients.

What Are Latest Mergers And Acquisitions In The Locally Advanced Pancreatic Cancer Market: AstraZeneca Strengthens Oncology Portfolio With Acquisition Of Fusion Pharmaceuticals

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This acquisition aims to enhance the oncology portfolio with advanced radiopharmaceuticals such as FPI-2265, strengthen research and development and manufacturing capabilities, and accelerate the shift to targeted cancer therapies while deepening its presence in Canada. Fusion Pharmaceuticals Inc. is a Canada-based biotechnology company actively developing targeted therapies for various cancers, including pancreatic cancer.

What Is The Regional Outlook For The Global Locally Advanced Pancreatic Cancer Market?

North America was the largest region in the locally advanced pancreatic cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the locally advanced pancreatic cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the locally advanced pancreatic cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Locally Advanced Pancreatic Cancer Market?

The locally advanced pancreatic cancer market consists of revenues earned by entities by providing services such as chemoradiation, palliative care, targeted therapy, and clinical trials. The market value includes the value of related goods sold by the service provider or included within the service offering. The locally advanced pancreatic cancer market also includes sales of CT scanners, MRI machines, brachytherapy systems, needle biopsy devices, and hemodynamic monitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Locally Advanced Pancreatic Cancer Industry?

The locally advanced pancreatic cancer market research report is one of a series of new reports from The Business Research Company that provides locally advanced pancreatic cancer market statistics, including the locally advanced pancreatic cancer industry's global market size, regional shares, competitors with a locally advanced pancreatic cancer market share, detailed locally advanced pancreatic cancer market segments, market trends and opportunities, and any further data you may need to thrive in the locally advanced pancreatic cancer industry. This locally advanced pancreatic cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Locally Advanced Pancreatic Cancer Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.05 billion
Revenue Forecast In 2034	$1.57 billion
Growth Rate	CAGR of 10.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The locally advanced pancreatic cancer market covered in this report is segmented – 1) By Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, Surgery 2) By Route Of Administration: Oral, Injectables, Other Route Of Administrations 3) By End-User: Hospital, Specialty Clinics, Research Institutions, Other End-Users Subsegments: 1) By Chemotherapy: Gemcitabine-based Chemotherapy, FOLFIRINOX Chemotherapy 2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines 3) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT) 4) By Surgery: Pancreaticoduodenectomy (Whipple Procedure), Distal Pancreatectomy, Total Pancreatectomy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Ipsen Biopharmaceuticals Inc., Lupin Limited, NovoCure Limited, Theratechnologies Inc., XBiotech, Prestige Biopharma, OSE Immunotherapeutics, Helix Biopharma Corporation, Fawn Incorporation, Eli Lilly and Co
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Locally Advanced Pancreatic Cancer Market Characteristics

3. Locally Advanced Pancreatic Cancer Market Trends And Strategies

4. Locally Advanced Pancreatic Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Locally Advanced Pancreatic Cancer Growth Analysis And Strategic Analysis Framework

5.1. Global Locally Advanced Pancreatic Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Locally Advanced Pancreatic Cancer Market Growth Rate Analysis

5.4. Global Locally Advanced Pancreatic Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Locally Advanced Pancreatic Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Locally Advanced Pancreatic Cancer Total Addressable Market (TAM)

6. Locally Advanced Pancreatic Cancer Market Segmentation

6.1. Global Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Immunotherapy

Radiation Therapy

Surgery

6.2. Global Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectables

Other Route Of Administrations

6.3. Global Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Specialty Clinics

Research Institutions

Other End-Users

6.4. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gemcitabine-based Chemotherapy

FOLFIRINOX Chemotherapy

6.5. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immune Checkpoint Inhibitors

Cancer Vaccines

6.6. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

External Beam Radiation Therapy

Stereotactic Body Radiation Therapy (SBRT)

6.7. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pancreaticoduodenectomy (Whipple Procedure)

Distal Pancreatectomy

Total Pancreatectomy

7. Locally Advanced Pancreatic Cancer Market Regional And Country Analysis

7.1. Global Locally Advanced Pancreatic Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Locally Advanced Pancreatic Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Locally Advanced Pancreatic Cancer Market

8.1. Asia-Pacific Locally Advanced Pancreatic Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Locally Advanced Pancreatic Cancer Market

9.1. China Locally Advanced Pancreatic Cancer Market Overview

9.2. China Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Locally Advanced Pancreatic Cancer Market

10.1. India Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Locally Advanced Pancreatic Cancer Market

11.1. Japan Locally Advanced Pancreatic Cancer Market Overview

11.2. Japan Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Locally Advanced Pancreatic Cancer Market

12.1. Australia Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Locally Advanced Pancreatic Cancer Market

13.1. Indonesia Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Locally Advanced Pancreatic Cancer Market

14.1. South Korea Locally Advanced Pancreatic Cancer Market Overview

14.2. South Korea Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Locally Advanced Pancreatic Cancer Market

15.1. Western Europe Locally Advanced Pancreatic Cancer Market Overview

15.2. Western Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Locally Advanced Pancreatic Cancer Market

16.1. UK Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Locally Advanced Pancreatic Cancer Market

17.1. Germany Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Locally Advanced Pancreatic Cancer Market

18.1. France Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Locally Advanced Pancreatic Cancer Market

19.1. Italy Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Locally Advanced Pancreatic Cancer Market

20.1. Spain Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Locally Advanced Pancreatic Cancer Market

21.1. Eastern Europe Locally Advanced Pancreatic Cancer Market Overview

21.2. Eastern Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Locally Advanced Pancreatic Cancer Market

22.1. Russia Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Locally Advanced Pancreatic Cancer Market

23.1. North America Locally Advanced Pancreatic Cancer Market Overview

23.2. North America Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Locally Advanced Pancreatic Cancer Market

24.1. USA Locally Advanced Pancreatic Cancer Market Overview

24.2. USA Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Locally Advanced Pancreatic Cancer Market

25.1. Canada Locally Advanced Pancreatic Cancer Market Overview

25.2. Canada Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Locally Advanced Pancreatic Cancer Market

26.1. South America Locally Advanced Pancreatic Cancer Market Overview

26.2. South America Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Locally Advanced Pancreatic Cancer Market

27.1. Brazil Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Locally Advanced Pancreatic Cancer Market

28.1. Middle East Locally Advanced Pancreatic Cancer Market Overview

28.2. Middle East Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Locally Advanced Pancreatic Cancer Market

29.1. Africa Locally Advanced Pancreatic Cancer Market Overview

29.2. Africa Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Locally Advanced Pancreatic Cancer Market Competitive Landscape And Company Profiles

30.1. Locally Advanced Pancreatic Cancer Market Competitive Landscape

30.2. Locally Advanced Pancreatic Cancer Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Locally Advanced Pancreatic Cancer Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company

31.2. AstraZeneca plc

31.3. Abbott Laboratories

31.4. Novartis AG

31.5. GSK plc

31.6. Ipsen Biopharmaceuticals Inc.

31.7. Lupin Limited

31.8. NovoCure Limited

31.9. Theratechnologies Inc.

31.10. XBiotech

31.11. Prestige Biopharma

31.12. OSE Immunotherapeutics

31.13. Helix Biopharma Corporation

31.14. Fawn Incorporation

31.15. Eli Lilly and Co

32. Global Locally Advanced Pancreatic Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Locally Advanced Pancreatic Cancer Market

34. Recent Developments In The Locally Advanced Pancreatic Cancer Market

35. Locally Advanced Pancreatic Cancer Market High Potential Countries, Segments and Strategies

35.1 Locally Advanced Pancreatic Cancer Market In 2029 - Countries Offering Most New Opportunities

35.2 Locally Advanced Pancreatic Cancer Market In 2029 - Segments Offering Most New Opportunities

35.3 Locally Advanced Pancreatic Cancer Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Locally Advanced Pancreatic Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Locally Advanced Pancreatic Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: F. Hoffmann-La Roche Ltd. Financial Performance

Table 80: Merck KGaA Financial Performance

Table 81: AbbVie Inc. Financial Performance

Table 82: Bayer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Locally Advanced Pancreatic Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Locally Advanced Pancreatic Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 80: Merck KGaA Financial Performance

Figure 81: AbbVie Inc. Financial Performance

Figure 82: Bayer Inc. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pancreatic Cancer Diagnostic Global Market Report 2025 – By Product (Instruments, Consumables, Services), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy), By Cancer Type (Exocrine, Adenocarcinoma, Squamous Cell Carcinoma, Adenosquamous Carcinoma, Colloid Carcinoma, Endocrine), By Test Type (Imaging Test, Biopsy, Blood Test, Genomic Test, Other Test Types), By End-User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2025 – By Therapies (Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications Approach), By Diagnostics (Blood Tests, Magnetic Resonance Imaging (MRI), Endoscopic Ultra-Sonography (EUS), Computerized Tomography (CT) Scanning), By Drug Type (Generic, Branded), By Distribution Channel (Direct Tender, Retail Pharmacy , Third-Party Distributor, Other Distribution Channels), By End User (Hospitals, Specialty Clinics, Homecare, Diagnostic Center, Research And Academic Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Exocrine Pancreatic Insufficiency Global Market Report 2025 – By Treatment (Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Other Treatments), By Diagnosis (Imaging Tests, Computed Tomography (CT) Scan, Abdominal Ultrasound, Secretin Pancreatic Function Test, Fecal Fat Test, Fecal Elastase Test (FE-–, Other Types), By Symptoms (Abdominal Pain, Constipation, Diarrhea, Fatty Stools, Weight Loss, Other Symptoms), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End Users (Hospitals, Specialty Clinics, Homecare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Global Market Report 2025 – By Product (Electrosurgery Instruments, Endoscope, Hand Instruments, Access Instruments, Stents, Energy/Vessel Sealing Devices, Visualization and Robotic Surgical System, Surgical Suture and Stapler Devices, Fluid Management System), By Indication (Liver Cancer, Pancreatic Cancer, Gall Stones, Bile Duct Cancer, Cirrhosis, Pancreatitis, Cholecystitis), By End User (Hospitals, Specialty Clinics, Trauma Centers, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Locally Advanced Pancreatic Cancer market?

How will the Locally Advanced Pancreatic Cancer market drivers and restraints affect the market dynamics? What forces will shape the Locally Advanced Pancreatic Cancer industry going forward?

The Locally Advanced Pancreatic Cancer market major growth driver - Impact Of Rising Tobacco Consumption On Health Risks. For further insights on the Locally Advanced Pancreatic Cancer market, request a sample here

What is the forecast market size or the forecast market value of the Locally Advanced Pancreatic Cancer market?

The Locally Advanced Pancreatic Cancer market size has grown strongly in recent years. The locally advanced pancreatic cancer market size has grown rapidly in recent years. It will grow from $0.95 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increase in awareness of pancreatic cancer, improved chemotherapy regimens, growth in use of targeted therapies, rise in incidence of pancreatic cancer, development of combination treatment protocols, and enhanced supportive care options. The locally advanced pancreatic cancer market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increase in awareness of pancreatic cancer, improved chemotherapy regimens, growth in use of targeted therapies, rise in incidence of pancreatic cancer, development of combination treatment protocols, and enhanced supportive care options. Major trends in the forecast period include advancements in immunotherapy, development of targeted therapies, enhanced precision radiation techniques, improved diagnostic imaging, adoption of minimally invasive surgical approaches, integration of artificial intelligence in treatment planning, and advancements in combination therapy. For further insights on the Locally Advanced Pancreatic Cancer market, request a sample here

How is the Locally Advanced Pancreatic Cancer market segmented?

The locally advanced pancreatic cancer market covered in this report is segmented –
1) By Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, Surgery
2) By Route Of Administration: Oral, Injectables, Other Route Of Administrations
3) By End-User: Hospital, Specialty Clinics, Research Institutions, Other End-Users

Subsegments:
1) By Chemotherapy: Gemcitabine-based Chemotherapy, FOLFIRINOX Chemotherapy
2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines
3) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT)
4) By Surgery: Pancreaticoduodenectomy (Whipple Procedure), Distal Pancreatectomy, Total Pancreatectomy For further insights on the Locally Advanced Pancreatic Cancer market, request a sample here

Which region has the largest share of the Locally Advanced Pancreatic Cancer market? What are the other regions covered in the report?

North America was the largest region in the locally advanced pancreatic cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the locally advanced pancreatic cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Locally Advanced Pancreatic Cancer market, request a sample here.

Who are the major players in the Locally Advanced Pancreatic Cancer market?

Major companies operating in the locally advanced pancreatic cancer market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Ipsen Biopharmaceuticals Inc., Lupin Limited, NovoCure Limited, Theratechnologies Inc., XBiotech, Prestige Biopharma, OSE Immunotherapeutics, Helix Biopharma Corporation, Fawn Incorporation, Eli Lilly and Co . For further insights on the Locally Advanced Pancreatic Cancer market, request a sample here.

What are the key trends in the Locally Advanced Pancreatic Cancer market?

Major trends in the Locally Advanced Pancreatic Cancer market include Innovative Approaches In Treating Rare Cancers With Orphan Drugs. For further insights on the Locally Advanced Pancreatic Cancer market, request a sample here.

What are the major opportunities in the Locally Advanced Pancreatic Cancer market? What are the strategies for the Locally Advanced Pancreatic Cancer market?

For detailed insights on the major opportunities and strategies in the Locally Advanced Pancreatic Cancer market, request a sample here.

How does the Locally Advanced Pancreatic Cancer market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Locally Advanced Pancreatic Cancer market growth and SWOT analysis of the Locally Advanced Pancreatic Cancer industry, request a sample here.

For detailed insights on Locally Advanced Pancreatic Cancer's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Locally Advanced Pancreatic Cancer industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Locally Advanced Pancreatic Cancer industry,

What are the key dynamics influencing the Locally Advanced Pancreatic Cancer market growth? SWOT analysis of the Locally Advanced Pancreatic Cancer market. request a sample here.